FIORENZATO, ELEONORA
 Distribuzione geografica
Continente #
NA - Nord America 1.298
EU - Europa 423
AS - Asia 104
AF - Africa 2
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.831
Nazione #
US - Stati Uniti d'America 1.290
IT - Italia 307
CN - Cina 84
SE - Svezia 29
DE - Germania 22
FI - Finlandia 18
NL - Olanda 12
IN - India 11
GB - Regno Unito 7
RU - Federazione Russa 6
MX - Messico 4
SG - Singapore 4
UA - Ucraina 4
FR - Francia 3
GR - Grecia 3
IE - Irlanda 3
CA - Canada 2
CH - Svizzera 2
CL - Cile 2
CU - Cuba 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
KR - Corea 2
NO - Norvegia 2
AU - Australia 1
BE - Belgio 1
BG - Bulgaria 1
ES - Italia 1
EU - Europa 1
HK - Hong Kong 1
ID - Indonesia 1
IR - Iran 1
Totale 1.831
Città #
Fairfield 217
Ashburn 150
Chandler 102
Woodbridge 99
Cambridge 93
Seattle 86
Houston 75
Wilmington 69
Padova 63
Milan 45
Rome 41
Beijing 40
Ann Arbor 31
San Diego 31
Princeton 30
Medford 29
Des Moines 26
Roxbury 18
Helsinki 16
Pune 9
Guangzhou 8
Nanjing 7
Boardman 6
Cagliari 6
Rovigo 6
Chita 5
Los Angeles 5
Naples 5
Shenyang 4
Vigonza 4
Apodaca 3
Athens 3
Barcellona Pozzo di Gotto 3
Bologna 3
Brendola 3
Chions 3
Dublin 3
Freiburg im Breisgau 3
Kharkiv 3
Nanchang 3
Ogden 3
Sassari 3
Wittnau 3
Apex 2
Bergamo 2
Budrio 2
Calalzo di Cadore 2
Cernusco sul Naviglio 2
Changsha 2
Chiavari 2
Council Bluffs 2
Dongguan 2
Fislisbach 2
Genoa 2
Groningen 2
Hanover 2
Havana 2
Heeze 2
Jiaxing 2
Las Vegas 2
Lecce 2
Limena 2
London 2
Matera 2
Oslo 2
Parkton 2
Parma 2
Pavia 2
Pescara 2
Québec 2
San Donato di Lecce 2
Santiago 2
Southwark 2
Stillwater 2
Stuttgart 2
Turin 2
Velappaya 2
Venice 2
Verona 2
Villanova 2
Wuhan 2
Amsterdam 1
Ardenno 1
Bayonne 1
Bolzano 1
Bordighera 1
Boydton 1
Brescia 1
Buffalo 1
Castiglione del Lago 1
Central 1
Chicago 1
Civitavecchia 1
Corbetta 1
Frankfurt am Main 1
Fuzhou 1
Ghent 1
Gorizia 1
Greifswald 1
Gwanak-gu 1
Totale 1.460
Nome #
Cognitive and Brain Imaging Changes in Parkinsonism 194
Brain structural profile of multiple system atrophy patients with cognitive impairment 103
Brain Amyloid Contribution to Cognitive Dysfunction in Early-Stage Parkinson's Disease: The PPMI Dataset 94
Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease 91
Dynamic functional connectivity changes associated with dementia in Parkinson's disease 86
Nonmotor Symptoms and Natural History of Parkinson's Disease: Evidence From Cognitive Dysfunction and Role of Noninvasive Interventions 74
Impact of Cognitive Profile on Impulse Control Disorders Presence and Severity in Parkinson's Disease 73
Anatomical profile of cognitive impairment in MSA 72
Do Old Errors Always Lead to New Truths? A Randomized Controlled Trial of Errorless Goal Management Training in Brain-Injured Patients 70
Cognitive impairment in multiple system atrophy 69
Double-blind randomized trial of t-DCS versus sham in Parkinson patients with mild cognitive impairment receiving cognitive training 68
Automated MRI Classification in Progressive Supranuclear Palsy: A Large International Cohort Study 65
Cognitive Rehabilitation in Parkinson's Disease: Is it Feasible? 59
Reply: Dynamic functional connectivity changes in Lewy body disease 58
A New MRI Measure to Early Differentiate Progressive Supranuclear Palsy From De Novo Parkinson's Disease in Clinical Practice: An International Study 57
Differences in cognitive profiles between Lewy body and Parkinson’s disease dementia 56
Cognitive and mental health changes and their vulnerability factors related to COVID-19 lockdown in Italy 55
Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease 53
The contribution of beta-amyloid to dementia in Lewy body diseases: a 1-year follow-up study 52
The interplay between asymmetric dopaminergic degeneration, brain structural changes and cognition in de-novo PD: The PPMI dataset 47
MoCA vs. MMSE sensitivity as screening instruments of cognitive impairment in PD, MSA and PSP patients 46
Cognitive profiling in patients with Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy: a 15-month longitudinal study 41
null 40
Safety and efficacy of cognitive rehabilitation in PD with cognitive impairments 38
Brain structural abnormalities in multiple system atrophy patients with cognitive impairment 31
Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy 31
Multimodal PET/MRI Study of Connectivity in Cognitively Impaired Patients with Parkinson’s Disease 27
Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes 25
Profile and progression of cognitive deficits in Progressive Supranuclear Palsy, Multiple System Atrophy and Parkinson's Disease 20
Quantification of Brain β-Amyloid Load in Parkinson's Disease With Mild Cognitive Impairment: A PET/MRI Study 19
Brain connectivity changes associated with t‐DCS and cognitive training plus cognitive training in Parkinson's disease with mild cognitive impairment 17
Performance at the Category-Exemplars language test (CATEX) in Parkinson's disease and Huntington's disease Italian population 14
The effectiveness of an immersive virtual reality and telemedicine-based cognitive intervention on prospective memory in Parkinson’s disease patients with mild cognitive impairment and healthy aged individuals: design and preliminary baseline results of a placebo-controlled study 10
Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy-Parkinsonism From Parkinson's Disease 9
Erratum: Double-blind Randomized Trial of tDCS Versus Sham in Parkinson Patients with Mild Cognitive Impairment Receiving Cognitive Training (Brain Stimulation (2015) 8 (1223-1225) DOI: 10.1016/j.brs.2015.07.043) 7
Validation of the Italian version of the Parkinson’s Disease- Cognitive Functional Rating Scale 5
Gender differences in the effects of emotion induction on intertemporal decision-making 5
One-year into COVID-19 pandemic: Decision-making and mental-health outcomes and their risk factors 4
null 4
The pharmacological management of the behavioral aspects of Parkinson’s disease: an update 3
Brain Dynamics Complexity as a Signature of Cognitive Decline in Parkinson's Disease 2
Biomarkers of aging in frailty and age-associated disorders: State of the art and future perspective 2
Attitudes Toward the Adoption of Remote Patient Monitoring and Artificial Intelligence in Parkinson’s Disease Management: Perspectives of Patients and Neurologists 1
Totale 1.897
Categoria #
all - tutte 8.187
article - articoli 5.716
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 262
Totale 14.165


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201949 0 0 0 0 0 0 0 0 0 8 24 17
2019/2020259 20 21 0 17 31 18 22 33 43 21 30 3
2020/2021292 11 6 7 12 8 57 18 22 44 34 44 29
2021/2022441 26 38 32 14 13 92 25 17 21 51 28 84
2022/2023396 58 8 15 20 60 53 4 46 72 10 33 17
2023/2024416 32 45 40 40 44 58 65 49 28 15 0 0
Totale 1.897